Zobrazeno 1 - 10
of 84
pro vyhledávání: '"W. Paul Dmowski"'
Publikováno v:
Revista Colombiana de Obstetricia y Ginecología, Vol 48, Iss 1 (1997)
Objetivos: Comparar los datos demográficos, epidemiológicos y médicos y evaluar las tendencias diagnósticas en mujeres con endometriosis y síntomas de dolor pé1vico crónico o endometriosis e infertilidad. Diseño: Análisis retrospectivo. Loc
Externí odkaz:
https://doaj.org/article/c9149e35e02b47649c672c59d74b381a
Autor:
Paul M Peloso, Mauricio Simões Abrão, Kristof Chwalisz, Sanjay K. Agarwal, Eric S. Surrey, Bruce R. Carr, Bruce A. Lessey, J. Chris Gallagher, B. Schwefel, W. Rachel Duan, Tomasz Rechberger, Juki Ng, Ahmed M. Soliman, Sukhbir Singh, Linda C. Giudice, Neil P. Johnson, James W Thomas, Hugh S. Taylor, Michael P. Diamond, Nicholas Leyland, Nelson B. Watts, David F. Archer, W. Paul Dmowski, James A. Simon
Publikováno v:
Obstetrics and gynecology. 132(1)
To evaluate the efficacy and safety of elagolix, an oral, nonpeptide gonadotropin-releasing hormone antagonist, over 12 months in women with endometriosis-associated pain.Elaris Endometriosis (EM)-III and -IV were extension studies that evaluated an
Autor:
W. Paul Dmowski, Christopher F. O'Brien, Joshua Burke, Roland Jimenez, Ping Jiang, Bruce R. Carr, Elizabeth Garner, Kristof Chwalisz
Publikováno v:
Reproductive Sciences. 21:1341-1351
This randomized double-blind study, with 24-week treatment and 24-week posttreatment periods, evaluated the effects of elagolix (150 mg every day, 75 mg twice a day) versus subcutaneous depot medroxyprogesterone acetate (DMPA-SC) on bone mineral dens
Autor:
William Koltun, Michael P. Diamond, Ping Jiang, Joshua Burke, W. Paul Dmowski, Bruce R. Carr, Roland Jimenez, Kristof Chwalisz, Christopher F. O'Brien, Elizabeth Garner
Publikováno v:
Reproductive Sciences. 21:363-371
This Phase 2 study evaluated the safety and efficacy of elagolix for treating endometriosis-associated pain. A total of 155 women with laparoscopically confirmed endometriosis were randomized to placebo, elagolix 150 mg, or elagolix 250 mg once daily
Autor:
Steven Hass, Kristof Chwalisz, Mahesh Fuldeore, Christopher F. O'Brien, Linda C. Giudice, W. Paul Dmowski, Roland Jimenez, Joshua Burke, Ping Jiang, Bruce R. Carr
Publikováno v:
Journal of Endometriosis and Pelvic Pain Disorders
Journal of endometriosis and pelvic pain disorders, vol 5, iss 3
Journal of endometriosis and pelvic pain disorders, vol 5, iss 3
Objective The aim of this study was to estimate the efficacy of elagolix, an oral gonadotropin-releasing hormone (GnRH) antagonist, for the treatment of endometriosis-associated pelvic pain. Methods This was a phase II, randomized, placebo-controlled
Publikováno v:
Journal of Assisted Reproduction and Genetics. 21:203-210
To compare the effects of two different blastocyst thawing protocols on implantation, pregnancy, and live birth rates.Ninety four consecutive frozen-thawed blastocyst transfers from 1996 to 2002 were retrospectively analyzed. Blastocysts were cryopre
Autor:
Donald P. Braun, W. Paul Dmowski
Publikováno v:
Best Practice & Research Clinical Obstetrics & Gynaecology. 18:245-263
Endometriosis is a benign gynecologic disorder characterized by the ectopic growth of misplaced endometrial cells. A unifying hypothesis to explain endometriosis has not been elucidated as yet but numerous investigations have implicated disturbances
Publikováno v:
The Journal of the American Association of Gynecologic Laparoscopists. 8:161-166
Small bowel involvement by endometriosis occurs in about 0.5% of patients, but nodular endometriosis involving the entire wall of the terminal ileum is extremely rare. Endometriotic nodules protruding into the intestinal lumen may lead to chronic, pa
Publikováno v:
Fertility and Sterility. 69:1103-1108
Objective: To compare the ability of peripheral blood monocytes (PBM) and peritoneal macrophages (PM) to mediate the in vitro cytolysis of endometrial cells from eutopic and ectopic endometrium in women with endometriosis. Design: Prospective study o
Publikováno v:
Fertility and Sterility. 68:538-541
Objective: To report an unusual case of embryo implantation and superfetation. Design: Retrospective case analysis. Setting: Oak Brook Fertility Center. Patient(s): A 41-year-old woman underwent two consecutive ovarian stimulation cycles interrupted